Interleukin-10 inhibits cytokine synthesis in monocytes stimulated by titanium particles: Evidence of an anti-inflammatory regulatory pathway

Journal of Orthopaedic Research

Volumn 16, Issue 6, 1998, Pages 697-704

  Pollice, P F ^a   Hsu, J ^a   Hicks, D G ^a   Bukata, S ^a   Rosier, R N ^a   Reynolds, P R ^a   Puzas, J E ^a   O'Keefe, R J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOCOMPATIBILITY; CELL CULTURE; DRUG DOSAGE; DRUG INTERACTIONS; FUNCTIONAL ASSESSMENT; TITANIUM;

ANTI INFLAMMATORY REGULATORY PATHWAY; CYTOKINE; INTERLEUKIN; MONOCYTES;

ORTHOPEDICS;

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TITANIUM; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYMPHOCYTE; MEDIATOR; MONOCYTE; PRIORITY JOURNAL;

EID: 0032215598     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100160611     Document Type: Article

References (34)

1. 1 Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology, 2nd ed. pp 246–251. Philadelphia, W. B. Saunders, 1994
2. 2 Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319: 516–518, 1986
3. 3 Blaine TA, Rosier RN, Puzas JE, Looney RJ, Reynolds PR, Reynolds SD, O'Keefe RJ: Increased levels of tumor necrosis factor‐alpha and interleukin‐6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg [Am] 78: 1181–1192, 1996
4. 4 Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M: Normal bronchial epithelial cells constitutively produce the anti‐inflammatory cytokine interleukin‐10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 13: 257–261, 1995
5. 5 Boynton E, Waddell JP, Morton J, Gardiner GW: Aseptic loosening in total hip implants: the role of polyethylene wear debris. Can J Surg 34: 599–605, 1991
6. 6 Burger D, Dayer JM: Inhibitory cytokines and cytokine inhibitors. Neurology 45: S39–S43. 1995
7. 7 Charnley J, Follacci FM, Hammond BT: The long‐term reaction of bone to self‐curina acrylic cement. J Bone Joint Surg [Br] 50: 822–829, 1968
8. 8 Davies DE, Lloyd JB: Monocyte‐to‐macrophage transition in vitro: a systematic study using human cells isolated by fractionation on Percoll. J Immunol Methods 118: 9–16, 1989
9. 9 de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL‐10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL‐10 produced by monocytes. J Exp Med 174: 1209–1220, 1991
10. 10 Donnelly RP, Freeman SL, Hayes MP: Inhibition of IL‐10 expression by IFN‐gamma upregulates transcription of TNF‐alpha in human monocytes. J Immunol 155: 1420–1427, 1995
11. 11 Friedman RJ, Black J, Galante JO, Jacobs JJ, Skinner HB: Current concepts in orthopaedic biomaterials and implant fixation. J Bone Joint Surg [Am] 75: 1086–1109, 1993
12. 12 Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 156: 1–4, 1996
13. 13 Goldman M, Marchant A, Schandene L: Endogenous interleukin‐10 in inflammatory disorders: regulatory roles and pharmacologic modulation. Ann NY Acad Sci 796: 282–293, 1996
14. 14 Horowitz SM, Doty SB, Lane JM, Burstein AH: Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg [Am] 75: 802–813, 1993
15. 15 Horowitz SM, Gonzales JB: Effects of polyethylene on macrophages. J Orthop Res 15: 50–56, 1997
16. 16 Howie DW, Haynes DR, Rogers SD, McGce MA, Pearcy MJ: The response to particulate debris. Orthop Clin North Am 24: 571–581, 1993
17. 17 Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH: Production of cytokincs around loosened cemented acetabular components: analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg [Am] 75: S63–S879, 1993
18. 18 Kadoya Y, Al‐Saffer N, Revell PA: Direct bone resorption by macrophages and their polykaryons in failed total joint arthroplasty. J Bone Miner Res (Suppl 1) 9: S3O9, 1994
19. 19 Kim KJ, Rubasi HE, Wilson SC, D Antonio JA, McClain EJ: A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop 287: 142–152, 1993
20. 20 Krakauer T: Evidence for protein kinase C pathway in the response of human peripheral blood mononuclear cells to cholera toxin. Cell Immunol 172: 224–228, 1996
21. 21 Le J, Vilcek J: Tumor necrosis factor and interleukin‐l: cytokines with multiple overlapping biological activities. Lab Invest 56: 234–248, 1987
22. 22 Lee SH, Brennan FR, Jacobs JJ, Urban RM, Ragasa DR, Glant TT: Human monocyte/macrophage response to cobalt‐chromium corrosion products and titanium particles in patients with total joint replacements. J Orthop Res 15: 40–49, 1997
23. 23 Maloney WJ, Jasty M, Harris WH, Galante JO, Callaghan JJ: Endosteal erosion in association with stable uncemented femoral components. J Bone Joint Surg [Am] 72: 1025–1034, 1990
24. 24 Maloney WJ, Woolson ST: Increasing incidence of femoral osteolysis in association with uncemented Harris‐Galante total hip arthroplasty: a follow‐up report. J Arthroplasty 11: 130–134, 1996
25. 25 Meisel C, Vogt K, Platzer C, Rando WF, Liebenthal C, Volk HD: Differential regulation of monocytic tumor necrosis factor‐alpha and interleukin‐10 expression. Eur J Immunol 26: 1580–1586, 1996
26. 26 Norwitz ER, Lopez Bernal A, Starkey PM: Tumor necrosis factor‐alpha selectively stimulates prostaglandin F2 alpha production by macrophages in human term decidua. Am J Obstet Gynecol 167: 815–820, 1992
27. 27 Parry SA, Sutherland CJ, Miller G, Gilden J, Joyce ME: Synovial fluid IL‐6 levels in failed total joint arthroplasty with osteolysis. Trans Orthop Res Soc 20: 216, 1995
28. 28 Platzer C, Meisel C, Vogt K, Platzer M, Volk HD: Up‐regulation of monocytic IL‐10 by tumor necrosis factor‐alpha and cAMP elevating drugs. Int Immunol 7: 517–523, 1995
29. 29 Quattrocchi KB, Miller CH, Wagner FC Jr, DeNardo SJ, De‐Nardo GL, Ovodov D, Frank EH: Cell‐mediated immunity in severely head‐injured patients: the role of suppressor lymphocytes and serum factors. J Neurosurg 77: 694–699, 1992
30. 30 Rennick D, Davidson N, Berg D: Interleukin‐10 gene knock‐out mice: a model of chronic inflammation. Clin Immunol Immunopathol 76: S174–S178, 1995
31. 31 Rogeer G, Andus T: Cytokines and inflammatory bowel disease. World J Surg 22: 382–389, 1998
32. 32 Roodman GD: Advances in bone biology: the osteoclast. Endocr Rev 17: 308–332, 1996
33. 33 Thomassen MJ, Divis LT, Fisher CJ: Regulation of human alveolar macrophage inflammatory cytokine production by interleukin‐10. Clin Immunol Immunopathol 80: 321–324, 1996
34. 34 Wanidworanun C, Strober W: Predominant role of tumor necrosis factor‐alpha in human monocyte IL‐10 synthesis. J Immunol 15: 6853–6861, 1993